Back
Becton Dickinson & Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
46
BDX
Becton Dickinson &
Last Price:
233.86
Seasonality Move:
0.03%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Sell
46
Becton Dickinson & (BDX)
is a Sell
Is Becton Dickinson & a Buy, Sell or Hold?
- The current Becton Dickinson & [BDX] share price is $233.87. The Score for BDX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- BDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BDX Stock Price Chart
What is Becton Dickinson &'s stock price today?
-
The Becton Dickinson & share price today is $233.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDX is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
BDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 47.65 | Sell |
Chaikin Money Flow: | -297429 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (230.09 - 238.53) | Sell |
Bollinger Bands (100): | (232.94 - 242) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 45.16 | Sell |
Chaikin Money Flow: | -377368 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
BDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 234.83 | Sell |
20-day SMA: | 234.61 | Sell |
50-day SMA: | 234.48 | Sell |
200-day SMA: | 242.52 | Sell |
8-day EMA: | 235.43 | Sell |
20-day EMA: | 235.17 | Sell |
50-day EMA: | 235.6 | Sell |
200-day EMA: | 241.54 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.13 | Sell |
20-day SMA: | 40.38 | Sell |
50-day SMA: | 41.72 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.68 | Sell |
20-day EMA: | 40.43 | Sell |
50-day EMA: | 41.92 | Sell |
200-day EMA: | 43.42 | Sell |
Becton Dickinson & Earnings Growth & BDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.66 per share, an increase next quarter of $0.54 per share, an increase this year of $0.89 per share, and an increase next year of $1.23 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Becton Dickinson & Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |